dc.contributor.author | Gungor, Yahya | |
dc.contributor.author | Kayatas, Mansur | |
dc.contributor.author | Yildiz, Gursel | |
dc.contributor.author | Ozdemir, Ozturk | |
dc.contributor.author | Candan, Ferhan | |
dc.date.accessioned | 2019-07-27T12:10:23Z | |
dc.date.accessioned | 2019-07-28T10:06:43Z | |
dc.date.available | 2019-07-27T12:10:23Z | |
dc.date.available | 2019-07-28T10:06:43Z | |
dc.date.issued | 2011 | |
dc.identifier.issn | 0886-022X | |
dc.identifier.issn | 1525-6049 | |
dc.identifier.uri | https://dx.doi.org/10.3109/0886022X.2011.552151 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/9711 | |
dc.description | WOS: 000287485800010 | en_US |
dc.description | PubMed ID: 21332339 | en_US |
dc.description.abstract | Background: In this study, we investigated the relationship between early arteriovenous fistula (AVF) thrombosis with angiotensin-converting enzyme (ACE) gene and thrombophilic factor gene polymorphisms. Methods: Thirty-five patients who suffered from three or more fistula thrombosis episodes in the early period after AVF operation and 33 control patients with no history of thrombosis for at least 3 years were enrolled in this study. Results: Factor V G1691A Leiden, factor V H1299R (R2), prothrombin G20210A, factor XIIIV34L, beta beta-fibrinogen-455 G-A, glycoprotein IIIa L33P human platelet antigens (HPA-1), methylenetetrahydrofolate reductase C677T, and methylenetetrahydrofolate reductase A1298C gene polymorphisms were similar in both groups (p > 0.05). Plasminogen activator inhibitor 1 (PAI-1) 4G//5G genotype in the study group and 4G//4G genotype in the control group were significantly higher (p == 0.014). No significant difference was detected in terms of the 5G//5G genotype. With regard to the ACE gene polymorphism, the control group showed more ID genotype (19//33, 57.6%%), whereas the study group showed more DD genotype (17//35, 48.6%%). II genotype was similar in both groups (x<SU2</SU == 7.40, p == 0.025). The rate of ACE inhibitor-angiotensin II receptor blockers use was 5//35 in the study group (14.3%%) and 5//33 in the control group (15.2%%). Individuals with PAI-1 4G//5G genotype showed 5.03 times more risk of thrombosis when compared with 4G//4G and 5G//5G genotypes [p == 0.008, OR == 5.03, 95%% confidence interval (1.44:17.64)]. Individuals with ACE DD genotype showed 4.25 times more risk of thrombosis when compared with II and ID [p == 0.008, OR == 4.25, 95%% confidence interval (1.404:12.83)]. Conclusion: PAI-1 4G//5G and ACE DD genotypes are associated with increased risk for early AVF thrombosis.</. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | TAYLOR & FRANCIS LTD | en_US |
dc.relation.isversionof | 10.3109/0886022X.2011.552151 | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | arteriovenous fistula | en_US |
dc.subject | hemodialysis | en_US |
dc.subject | ACE gene polymorphism | en_US |
dc.subject | PAI-1 4G/5G | en_US |
dc.subject | thrombophilia | en_US |
dc.title | The Presence of PAI-1 4G/5G and ACE DD Genotypes Increases the Risk of Early-Stage AVF Thrombosis in Hemodialysis Patients | en_US |
dc.type | article | en_US |
dc.relation.journal | RENAL FAILURE | en_US |
dc.contributor.department | [Kayatas, Mansur -- Yildiz, Gursel -- Candan, Ferhan] Cumhuriyet Univ Hastanesi, Dept Nephrol, Fac Med, TR-58140 Sivas, Turkey -- [Gungor, Yahya] Cumhuriyet Univ Hastanesi, Fac Med, Dept Internal Med, TR-58140 Sivas, Turkey -- [Ozdemir, Ozturk] Cumhuriyet Univ Hastanesi, Fac Med, Dept Med Biol & Genet, TR-58140 Sivas, Turkey | en_US |
dc.identifier.volume | 33 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.endpage | 175 | en_US |
dc.identifier.startpage | 169 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |